| Antibody response to SARS-CoV-2 infection in humans: A systematic review N Post, D Eddy, C Huntley, MCI Van Schalkwyk, M Shrotri, D Leeman, ... PloS one 15 (12), e0244126, 2020 | 401 | 2020 |
| SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study A Shields, SE Faustini, M Perez-Toledo, S Jossi, E Aldera, JD Allen, ... Thorax 75 (12), 1089-1094, 2020 | 323* | 2020 |
| Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine RP Payne, S Longet, JA Austin, DT Skelly, W Dejnirattisai, S Adele, ... Cell 184 (23), 5699-5714. e11, 2021 | 288 | 2021 |
| COVID-19 in patients with primary and secondary immunodeficiency: the United Kingdom experience AM Shields, SO Burns, S Savic, AG Richter, A Anantharachagan, ... Journal of Allergy and Clinical Immunology 147 (3), 870-875. e1, 2021 | 226 | 2021 |
| T-cell and antibody responses to first BNT162b2 vaccine dose in previously SARS-CoV-2-infected and infection-naive UK healthcare workers: a multicentre, prospective … A Angyal, S Longet, S Moore, RP Payne, A Harding, T Tipton, P Rongkard, ... The Lancet Microbe, 2021 | 188* | 2021 |
| T cell response to SARS-CoV-2 infection in humans: A systematic review M Shrotri, MCI van Schalkwyk, N Post, D Eddy, C Huntley, D Leeman, ... PloS one 16 (1), e0245532, 2021 | 140 | 2021 |
| UBE2L3 polymorphism amplifies NF-κB activation and promotes plasma cell development, linking linear ubiquitination to multiple autoimmune diseases MJ Lewis, S Vyse, AM Shields, S Boeltz, PA Gordon, TD Spector, ... The American Journal of Human Genetics 96 (2), 221-234, 2015 | 108* | 2015 |
| Resolution-associated molecular patterns (RAMP): RAMParts defending immunological homeostasis? AM Shields, GS Panayi, VM Corrigall Clinical & Experimental Immunology 165 (3), 292-300, 2011 | 106 | 2011 |
| Development of a high‐sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS‐CoV‐2 spike glycoprotein in serum and saliva SE Faustini, SE Jossi, M Perez‐Toledo, AM Shields, JD Allen, ... Immunology 164 (1), 135-147, 2021 | 91* | 2021 |
| Sensitive detection of SARS-CoV-2–specific antibodies in dried blood spot samples GL Morley, S Taylor, S Jossi, M Perez-Toledo, SE Faustini, ... Emerging infectious diseases 26 (12), 2970, 2020 | 81 | 2020 |
| Safety and 30-day outcomes of tracheostomy for COVID-19: a prospective observational cohort study O Breik, P Nankivell, N Sharma, MN Bangash, C Dawson, M Idle, ... British Journal of Anaesthesia 125 (6), 872-879, 2020 | 75 | 2020 |
| COVID-19: seroprevalence and vaccine responses in UK dental care professionals AM Shields, SE Faustini, CA Kristunas, AM Cook, C Backhouse, L Dunbar, ... Journal of dental research 100 (11), 1220-1227, 2021 | 68* | 2021 |
| Establishing the prevalence of common tissue-specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection AG Richter, AM Shields, A Karim, D Birch, SE Faustini, L Steadman, ... Clinical & Experimental Immunology 205 (2), 99-105, 2021 | 66 | 2021 |
| SARS‐CoV‐2‐specific IgG1/IgG3 but not IgM in children with pediatric inflammatory multi‐system syndrome M Perez‐Toledo, SE Faustini, SE Jossi, AM Shields, E Marcial‐Juarez, ... Pediatric Allergy and Immunology 32 (5), 1125-1129, 2021 | 65* | 2021 |
| Treatment of chronic or relapsing COVID-19 in immunodeficiency LAK Brown, E Moran, A Goodman, H Baxendale, W Bermingham, ... Journal of Allergy and Clinical Immunology 149 (2), 557-561. e1, 2022 | 63 | 2022 |
| Validation of a combined ELISA to detect IgG, IgA and IgM antibody responses to SARS-CoV-2 in mild or moderate non-hospitalised patients AM Cook, SE Faustini, LJ Williams, AF Cunningham, MT Drayson, ... Journal of immunological methods 494, 113046, 2021 | 51 | 2021 |
| Vitamin D status and seroconversion for COVID-19 in UK healthcare workers AA Faniyi, ST Lugg, SE Faustini, C Webster, JE Duffy, M Hewison, ... European Respiratory Journal 57 (4), 2021 | 48 | 2021 |
| Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response AM Shields, SE Faustini, M Perez-Toledo, S Jossi, JD Allen, S Al-Taei, ... BMJ open respiratory research 8 (1), e000872, 2021 | 46 | 2021 |
| SARS-CoV-2 vaccine responses in individuals with antibody deficiency: findings from the COV-AD study AM Shields, SE Faustini, HJ Hill, S Al-Taei, C Tanner, F Ashford, ... Journal of clinical immunology 42 (5), 923-934, 2022 | 45 | 2022 |
| Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK AM Shields, A Anantharachagan, G Arumugakani, K Baker, S Bahal, ... Clinical and experimental immunology 209 (3), 247-258, 2022 | 33 | 2022 |
